VEGFA and retinopathy of prematurity: Since 2011, treatment of ROP using intravitreal injections of anti-VEGF agents have further improved structural outcomes for infants with posterior stage 3 ROP in the presence of plus disease [36] or aggressive posterior ROP (AP-ROP) [37].